NEW ORLEANS – A new biologic medication – the first for HIV – is showing promise in treating patients with multidrug resistance, according to phase 3 research being presented at IDWeek 2016™.
Originally posted here:
New drug benefits patients with multi-drug resistant HIV
Scientists at Brigham and Women’s Hospital say they have found two new potential drug targets for treating arterial diseases such as atherosclerosis.
Read the original:
Proteomics Technique Identifies Two New Drug Targets for Treating Atherosclerosis
Dr Sylwia Ammoun, Senior Research Fellow at Plymouth University Peninsula Schools of Medicine and Dentistry, has received backing from children’s charity Action Medical Research, to investigate new drug treatments for neurofibromatosis 2 (NF2 …
Read the rest here:
Could DNA from a virus millions of years old hold the key to new neuro tumor therapies?
New drugs typically take 12-14 years to make it to market, with a 2014 report finding that the average cost of getting a new drug to market had ballooned to a whopping $2.6 billion.
Using machine learning to make drug discovery more efficient
MANILA A mayor on Philippine President Rodrigo Duterte’s wanted list for alleged drugs links was killed along with nine of his guards in a shootout on Friday, police said, as a new phase of a bloody narcotics crackdown zeroed-in on high profile targets.
View original post here:
Philippine mayor among 10 killed in shootout as drug war enters new phase
PITTSBURGH (KDKA) — Three years ago when Linda Malsch found a lump under her arm – she feared it was cancer.
New Drug Showing Promise In The Treatment Of Cancer
U-47700 is the latest superdrug invading Florida, and you’ve probably never heard of it. Unlike other drugs, it has no medical use. “It’s causing psychotic disorders like we’ve never seen before,” said Tommy Lloyd, program director at Springs …
Continue reading here:
Synthetic drug new to Florida has high potential for abuse
It was tested for long-term effectiveness for more than two years in 1,000 trials patients, both children and adults. Marketed as Orkambi, the drug reduced the rate of lung decline by 42 per cent and caused a 35 per cent drop in the number of serious …
Read the original post:
Could THIS increase life expectancy for cystic fibrosis patients? New drug slows irreversible lung damage by ‘more than 40%’
Every five years, the pharmaceutical industry negotiates “user fees” they’ll pay the FDA to review new drug applications.
In Washington’s drug price fight, plenty of blame to go around
FoCUS is an undertaking of the MIT Center for Biomedical Innovation (CBI) NEWDIGS (NEW Drug Development ParadIGmS) Initiative, which focuses on re-engineering drug development and delivery processes to optimize benefit and access to new medicines for …
Read the original post:
MIT center convenes healthcare leaders to pioneer new pharmaceutical financing strategies